NYSE American - Delayed Quote • USD
Electromed, Inc. (ELMD)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 4:05 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | 0.13 | 0.14 | 0.47 | 0 |
| Low Estimate | 0.13 | 0.14 | 0.47 | 0 |
| High Estimate | 0.13 | 0.14 | 0.47 | 0 |
| Year Ago EPS | 0.12 | 0.12 | 0.36 | 0.47 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 13.8M | 15M | 54.7M | 60.4M |
| Low Estimate | 13.8M | 15M | 54.7M | 60.4M |
| High Estimate | 13.8M | 15M | 54.7M | 60.4M |
| Year Ago Sales | -- | 13.61M | 48.07M | 54.7M |
| Sales Growth (year/est) | -- | 10.20% | 13.80% | 10.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.1 | 0.13 | 0.1 | 0.1 |
| EPS Actual | 0.12 | 0.12 | 0.02 | 0.19 |
| Difference | 0.02 | -0.01 | -0.08 | 0.09 |
| Surprise % | 20.00% | -7.70% | -80.00% | 90.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.13 | 0.14 | 0.47 | 0 |
| 7 Days Ago | 0.13 | 0.14 | 0.47 | 0.43 |
| 30 Days Ago | 0.13 | 0.14 | 0.47 | 0.43 |
| 60 Days Ago | 0.13 | 0.14 | 0.47 | 0.43 |
| 90 Days Ago | 0.12 | 0.13 | 0.38 | 0.43 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ELMD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 8.30% | -- | -- | 1.50% |
| Next Qtr. | 16.70% | -- | -- | 11.40% |
| Current Year | 30.60% | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -4.55% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | EF Hutton: Buy to Buy | 5/11/2023 |
| Maintains | EF Hutton: Buy | 2/16/2023 |
| Maintains | Lake Street: Buy | 2/15/2023 |
| Initiated | EF Hutton: Buy | 9/6/2022 |
| Initiated | Lake Street: Buy | 8/5/2022 |
| Initiated | Northland Capital Markets: Outperform | 11/24/2020 |
Related Tickers
AXGN AxoGen, Inc.
6.87
-1.43%
CLPT ClearPoint Neuro, Inc.
5.32
-3.27%
IRMD IRADIMED CORPORATION
42.44
+1.29%
ENCW Enchanted World Inc.
0.0003
0.00%
XVIPF Xvivo Perfusion AB (publ)
33.53
+13.74%
ESMC Escalon Medical Corp.
0.2400
0.00%
SONVY Sonova Holding AG
55.91
+0.11%
CNMD CONMED Corporation
70.01
-1.82%
BSX.MX Boston Scientific Corporation
1,247.96
+7.11%
LNSR LENSAR, Inc.
3.2600
+2.52%